Naltrexone And Bupropion
A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects
Orexigen Therapeutics, Inc · Phase 3 · Completed · Enrollment 1742
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| NB16 | 39.49% | 20.17% | n/r | n/r |
| NB32 | 47.98% | 24.63% | n/r | n/r |
| Placebo | 16.44% | 7.44% | n/r | n/r |
Not shown
Every selected arm is drawn.